UK trade deal with US must not lead to drug price rises, say doctorsBMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3604 (Published 16 September 2020) Cite this as: BMJ 2020;370:m3604
- Elisabeth Mahase
- The BMJ
The BMA must work to ensure that any future trade deal between the UK and the US does not lead to a rise in the price of medicines or weaken the UK’s ability to negotiate prices with US companies, doctors have said.
Delegates at the BMA annual representative meeting on 15 September voted for the motion, which also called for the BMA to lobby the relevant organisations to ensure that any such trade deal “does not adversely affect the safety …